A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC - Contacts and Locations

A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC

This study has been completed.

Study NCT00000718. Last updated on July 28, 2008. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000718

Locations


United States, California
	Univ of California / San Diego Treatment Ctr
	San Diego, California, United States, 921036325
	Stanford Univ School of Medicine
	Stanford, California, United States, 94305
	Los Angeles County - USC Med Ctr
	Los Angeles, California, United States, 90033

United States, District of Columbia
	George Washington Univ Med Ctr
	Washington, District of Columbia, United States, 20037

United States, Florida
	Univ of Miami School of Medicine
	Miami, Florida, United States, 331361013

United States, Illinois
	Rush Presbyterian - Saint Luke's Med Ctr
	Chicago, Illinois, United States, 60612
	Northwestern Univ Med School
	Chicago, Illinois, United States, 60611

United States, Louisiana
	Charity Hosp / Tulane Univ Med School
	New Orleans, Louisiana, United States, 70112
	Louisiana State Univ Med Ctr / Tulane Med School
	New Orleans, Louisiana, United States, 70112
	Tulane Univ School of Medicine
	New Orleans, Louisiana, United States, 70112

United States, Massachusetts
	Harvard (Massachusetts Gen Hosp)
	Boston, Massachusetts, United States, 02114

United States, Minnesota
	Univ of Minnesota
	Minneapolis, Minnesota, United States, 55455

United States, New York
	Saint Luke's - Roosevelt Hosp Ctr
	New York, New York, United States, 10025

United States, South Carolina
	Julio Arroyo
	West Columbia, South Carolina, United States, 29169

Sponsors and Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Hoffmann-La Roche

Investigators


Study Chair:	G Skowron